GI-Certified Sarawak Pepper Positioned for Greater Global Recognition

GI-Certified Sarawak Pepper Positioned for Greater Global Recognition

KUALA LUMPUR, Malaysia, Oct. 15, 2026 /PRNewswire/ -- The Malaysian Pepper Board (MPB) has launched an international communications initiative to further promote Sarawak Pepper to global buyers, positioning GI-certified Sarawak Pepper as one of...

TestMu AI Positioned as a Leader in the 2026 Gartner® Magic Quadrant™ for Agentic Software Quality Assurance Platforms

TestMu AI Positioned as a Leader in the 2026 Gartner® Magic Quadrant™ for Agentic Software Quality Assurance Platforms

Evaluation Based on Completeness of Vision and Ability to Execute NOIDA, India, Oct. 10, 2026 /PRNewswire/ -- TestMu AI, the Full-Stack Agentic AI Quality Engineering platform, announced it has been positioned as a Leader in the 2026 Gartner® Magic...

Digital Prime Technologies Announces Continued Expansion of Its Digital Asset Financing Marketplace as Leading Global Institutions Accelerate Adoption

Digital Prime Technologies Announces Continued Expansion of Its Digital Asset Financing Marketplace as Leading Global Institutions Accelerate Adoption

Launch partners bring more than $1 billion both in inventory and demand to Tokenet, following strategic investment from and partnership with EquiLend NEW YORK, July 29, 2026 /PRNewswire/ -- Digital Prime Technologies ("DPT") today announced the...

Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies

Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies

SHANGHAI, April 10, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today announced the cumulative closing of a pre-IPO financing...

VivaVision Announces Positive Comments from FDA for the Type C Meeting Regarding VVN461LD for Post-operative Infalmmation - Agreeing the Phase 2 Trial to Be Served as One of the Two Pivotal Studies.

VivaVision Announces Positive Comments from FDA for the Type C Meeting Regarding VVN461LD for Post-operative Infalmmation - Agreeing the Phase 2 Trial to Be Served as One of the Two Pivotal Studies.

HONG KONG and WENZHOU, China, June 10, 2025 /PRNewswire/ -- VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced today that it received written...

menu
menu